The IMAP Study Improving Management of Mildly Abnormal Pap Smears
HPV DNA Testing Versus Conventional Management for Women With Minor Atypia on Pap Smear: Psychosocial and Quality of Life Outcomes and Development of a Decision Analytic Model
Sponsor: Family Planning Association New South Wales
A PHASE3 clinical study on Cervix Neoplasms, this trial is ongoing. The trial is conducted by Family Planning Association New South Wales and has accumulated 5 data snapshots since 2004. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE3
First recorded
Jan 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Family Planning Association New South Wales
- National Health and Medical Research Council, Australia
- University of Sydney
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Adelaide, Australia
- • Brisbane, Australia
- • Perth, Australia
- • Port Macquarie, Australia
- • Sydney, Australia
- • Taree, Australia
- • Warilla, Australia